N. Reese

High-Dose Cytarabine (HD araC) in the Treatment of Leukemias: a Review

G. Schiller, N. Reese, 2013, Current Hematologic Malignancy Reports.

Myelodysplasia

M. Wadleigh, G. Schiller, N. Reese, 2001, Bone Marrow Transplantation.

Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization

S. Dry, W. Tap, D. Slamon, 2011, Genes, chromosomes & cancer.

A Phase II Study of Pembrolizumab in EGFR‐Mutant, PD‐L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC

J. Horton, J. Goldman, E. Garon, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A phase II study of pembrolizumab in EGFR-mutant, PD-L1+, tyrosine kinase inhibitor (TKI) naïve patients with advanced NSCLC.

J. Goldman, E. Garon, C. Wells, 2018 .

MA 02.07 A Phase II Study of Pembrolizumab in EGFR Mutant, PD-L1+, Tyrosine Kinase Inhibitor (TKI) Naïve Patients with Advanced NSCLC

J. Goldman, E. Garon, A. Lisberg, 2017 .